At a Senate Finance Committee hearing, Sen. Peter Welch tells RFK Jr. that drug companies with TrumpRx deals got relief from Trump's tariffs, while everyday Americans see no drop in prescription costs. Kennedy says the tariff relief applies only if companies move production to the US. Welch says all but one of the 16 TrumpRx companies have raised prices since their deals, and that the companies gained $1.3 trillion in market value.
The receipt
- Who
- Sen. Peter Welch
- Where
- hearing - Senate Finance Committee
- Original footage
- Forbes Breaking News · watch the full video from this moment
- Length
- 60 seconds, unedited within the cut
Read the transcript
You know, you mentioned that there was $1 .3 trillion in market increase for the drug companies. But I'm not seeing any reduction in cost to everyday Americans who want to get prescription drugs. Drug companies who made these deals were given exemption from Trump tariffs, right? They got a quick... They're only if they move their production to this country. Well, so they got a tariff reduction. They got a tariff arbitrarial only if they produce here and they get it for if they make a commitment to produce here, they can get it a year in advance. All right. Thank you for that clarification. But what I understand is that all but one of the 16 Trump Rx companies have increased prescription drug prices since making their deals. The prices are going up. companies that signed deals made even more money you mentioned 1 .3 trillion dollars in market value increase
Machine transcript of the clip's audio; names are checked, small words may differ.